aMoon
SelectiveFiled to raiseRaanana, IsraelBiotechnology, Healthcare, PharmaceuticalsLast fund filed 2021
4 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| aMoon Edge | March 2021 | Indefinite | $43M | 12 |
| aMoon Growth Fund IIFiled to raise in 2021, with no closing reported yet. | 2021 | Indefinite | $0 | 0 |
| aMoon Velocity Fund | March 2019 | Indefinite | $7.3M | 5 |
| aMoon 2 Fund | June 2018 | $120M | $692M | 23 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
5 partners are named across this firm’s filings, 4 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Patrick Rivers | Slowing | None listed | 1 | 1 |
| Reut Shema | Slowing | None listed | 1 | 1 |
| Todd SoneNot on the current fund | Slowing | Biotech & pharma, Medical devices | 4 | 1 |
| Tomer Berkovitz | Quiet | None listed | 0 | 0 |
| Yair Schindel | Quiet | Biotech & pharma, Healthcare services | 4 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Classified sectors of aMoon’s own portfolio companies, based on 6 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of aMoon’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| Caduceus Capital | 1 | Adicet Bio |
| Khosla Ventures | 1 | Scipher Medicine |
| Orbimed Genesis | 1 | Adicet Bio |
| Polaris Partners | 1 | Satellite Biosciences |
| Town Hall Ventures | 1 | HOPSCOTCH HEALTH HOLDINGS |
| U.S Venture Partners | 1 | Iantrek |
| Wrangler | 1 | Better Life Partners |
A shared board seat: a company where filings name a aMoon partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.